NCT05356416 is a NA clinical trial of Ischemic compression in Scalenus Syndrome, sponsored by Riphah International University.

Who is sponsoring NCT05356416?

NCT05356416 is sponsored by Riphah International University.

What drugs are being tested in NCT05356416?

Interventions in NCT05356416: Ischemic compression, Dry needling.

What condition does NCT05356416 study?

NCT05356416 studies Scalenus Syndrome.

Is NCT05356416 still recruiting?

NCT05356416 is currently completed. Last updated 9 November 2022.

Last reviewed 2022-11-09 · How we verify

NCT05356416

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparative Effects of Dry Needling and Ischemic Compression Technique on Scalene Myofascial Pain Syndrome

Completed NA Last updated 9 November 2022

What this trial tests

NA trial testing Ischemic compression in Scalenus Syndrome in 28 participants. Completed in 18 October 2022.

Timeline

6 May 2022

Primary endpoint
6 October 2022

18 October 2022

Quick facts

Lead sponsor	Riphah International University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	28
Start date	6 May 2022
Primary completion	6 October 2022
Estimated completion	18 October 2022
Sites	1 location across Pakistan

Drugs / interventions tested

Ischemic compression
Dry needling

Conditions studied

Scalenus Syndrome — all drugs for Scalenus Syndrome →

Sponsor

Riphah International University

Who can join

Adults 18 to 45, any sex, with Scalenus Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Myofascial Pain Syndrome (MPS) is a medical term used to describe chronic regional pain syndrome that presents with hyperirritable spots called trigger points (TPs) and/or tender spots (TSs) that arise from taut bands (TB) in the skeletal muscle. Scalene myofascial pain syndrome is a regional pain syndrome wherein pain originates over the neck area and radiates down to the arm. Functionally, MPS causes the muscle to become weak and stiff, leading to reductions in range of movement. Thus, MPS is known as a major cause of morbidity, with a significant impact on daily activity, function and quality of life. The aim of this study is to compare the effects of dry needling versus ischemic compression technique on trigger points of scalene in neck pain, related disability and neck active range of motion among patients with scalene myofascial pain syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ischemic compression

Trials testing the same drug.

NCT06530329 — Short-Term Effects of Ischemic Compression Applied in Addition to Classical Massage in the Treatment of Trigger Points · NA · completed
NCT04122352 — The Effects of Trigger Point Treatment in Temporomandibular Joint Dysfunction · NA · completed
NCT03708107 — Percutaneous Microelectrolysis (MEP) Versus Ischemic Compression in Miofascial Trigger Points · NA · completed
NCT03273985 — Effectiveness of Dry Needling in Shortened Triceps Surae Muscle · NA · completed
NCT05546203 — Trigger Point Treatment in Chronic Pelvic Pain · NA · completed

Other Riphah International University trials

Trials by the same sponsor.

NCT07579585 — Effects of Photobiomodulation in Hemophilia Patients. · NA · recruiting
NCT07504276 — Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors. · NA · recruiting
NCT07484477 — Sedentary Behavior Modification, Cardiopulmonary Function & QOL Post Cardiac Surgery Patients. · NA · not yet recruiting
NCT07438587 — Comparative Effects of Cadence Training vs Elliptical Training in Cricketers · NA · not yet recruiting
NCT07484399 — Comparing Effects of HIIT and MICT on Functional Mobility, Muscle Strength, and Quality of Life in Diabetic Patients · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05356416 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Riphah International University
Last refreshed: 9 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05356416.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing